Introducing ICRF’s Harry Lebovic
Young Jewish Leadership Award
This NEW ICRF award was presented annually at ICRF Toronto’s signature Revolving Tables event, that took place this year on March 26. It honours an outstanding young Jewish leader who exemplifies innovation, commitment, and service values that align with ICRF’s mission and Mr. Lebovic’s enduring legacy of leadership.
We extend our heartfelt thanks to Harry Lebovic for his vision, leadership, and generosity in establishing the ICRF Harry Lebovic Young Jewish Leadership Award. His commitment ensures that emerging leaders who embody innovation, service, and Jewish values are recognized and celebrated.
The recipient will be recognized for making a meaningful and measurable impact within the Jewish community, embodying core values such as tzedakah and tikkun olam, bringing innovative and forward-thinking leadership to communal challenges, and showing exceptional promise for long-term influence. The awardee is also someone acknowledged by peers as ethical, collaborative, and inspiring.
Know a Young Jewish Leader in our Community? Let us know!
Finding treatments and cures for all forms of cancer
Our mission is to continue to find treatments and cures for all forms of cancer, utilizing the unique benefits Israel and its scientists have to offer. The results of the research have a significant impact in Toronto, across Canada and throughout the world.
ICRF has funded two Nobel laureates and many other distinguished scientists working in Israeli hospitals, universities and other research institutions.
Israel Cancer Research Fund has over 45 years of history fighting cancer, and we anticipate continued success along the road to the cures. With the valuable assistance of ICRF-funded scientists and our international family of friends, we feel confident that those cures will come from Israel.
Why ICRF
Superb Scientists
Israel has the highest concentration of scientists and physicians per capita
Cost-effective research
Funding scientists in Israel has 30% less overhead costs than North American research
Institution Neutral
Funding goes to scientists at all of Israel’s top biomedical research centers
Targeted Funding
ICRF directly funds individual vetted scientists, rather than “bricks and mortar”
UPCOMING EVENTS
ICRF In the News
ICRF Funded Researcher Yinon Ben-Neriah publishes paper in Nature
nature.com
Yinon Ben-Neriah, ICRF Funded Researcher publishes paper in Nature: The gut microbiome switches mutant p53 from tumour-suppressive to oncogenic Somatic mutations in p53, which inactivate the tumour-suppressor function of p53 and often confer oncogenic gain-of-function properties, are very common in cancer.
Overcoming melanoma’s resistance to anti-cancer drugs
breakingisraelnews.com
Melanoma often presents a rapid resistance to molecular anti-cancer therapies. Although there have been advances in targeted and immunotherapy melanoma treatments in recent years, a substantial percentage of patients fail to respond or develop resistance to such therapies.
Israeli researchers make key discovery that could lead to skin cancer vaccine
israelnationalnews.com
A new study conducted at Tel Aviv University and the Sheba Medical Center reveals how melanoma cancer cells affect their close environment to support their needs – by forming new lymph vessels in the dermis in order to go deeper into the skin and spread through the body. The researchers believe that the new discovery may contribute to the development of a vaccine against the deadly cancer.
Sign up for our newsletter
Our monthly newsletters provide a snapshot of our recent publications and activities, as well as information on our upcoming events. Subscribe to receive the latest from ICRF Toronto.
Join our mission to eradicate cancer in our lifetime
Israel Cancer Research Fund has over 49 years of history fighting cancer, and we anticipate continued success along the road to the cures. With the valuable assistance of ICRF-funded scientists and our international family of friends, we feel confident that those cures will come from Israel.
Donate today
